Multiple layers were integrated to select a subset of molecular components, which might suggest that mitochondrial and metabolic dysfunction are contributors to long-term symptoms following critical COVID-19
In this context, glutaminase 1 (GLS1), expressed in the mitochondria of several malignant tumors (ovarian cancer, breast tumor cells, colorectal cancer), promotes glutamine degradation to support cellular proliferation [200,201,202]
In all patients with moderate MG that died, median time to death (13/65, 20%) was 25 days, range 1431 days, and in the second group (20/65, 31%), the median time to death was 14 days with a range of 926 days
Test subjects also showed lower risk of Alzheimer's disease and lower consumption of alcohol and cigarettes while using the medication